PharmaResearch Co., Ltd. (KOSDAQ:214450)

Market Cap	6.01T
Revenue (ttm)	449.81B
Net Income (ttm)	126.99B
Shares Out	10.39M
EPS (ttm)	12,241.81
PE Ratio	47.22
Forward PE	28.62
Dividend	1,100.00 (0.20%)
Ex-Dividend Date	Dec 27, 2024

Volume	225,476
Average Volume	120,897
Open	547,000
Previous Close	547,000
Day's Range	533,000 - 580,000
52-Week Range	187,400 - 713,000
Beta	0.60
RSI	40.89
Earnings Date	Nov 13, 2025

About PharmaResearch

PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients; PLACENTEX injection for the treatment and tissue restoration of wounds; CLEVIEL VOLUME to temporarily improve facial wrinkles in adults thro...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1993
• Employees: 450
• Stock Exchange: KOSDAQ
• Ticker Symbol: 214450

Financial Performance

In 2024, PharmaResearch's revenue was 350.12 billion, an increase of 34.14% compared to the previous year's 261.01 billion. Earnings were 92.04 billion, an increase of 20.24%.